Home/ Supplements/ Nmn/ NMN 175 mg

NMN 175 mg

product on market Capsule California Gold Nutrition Safety: 60/100
60/100

Review before taking

  • Beta-Nicotinamide Mononucleotide: 175mg is 5.0× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Beta-Nicotinamide Mononucleotide is researched for its role in increasing NAD+ levels to support cellular energy and metabolism, though human evidence remains limited. Due to a safety score of 60, potential concerns regarding long-term tolerability should be noted. Users should consult a professional regarding these safety considerations.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Beta-Nicotinamide Mononucleotide: 175mg is 5.0× the Tolerable Upper Intake Level (35mg)

✨ AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a low safety score because it contains 175mg of Beta-Nicotinamide Mononucleotide, which is five times higher than the recommended upper intake limit of 35mg.

Label

Product Label

Label for NMN 175 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Exceeds UL by 5.0× (UL: 35 mg) 196 studies (A:5, B:63)

Other Ingredients

Gum Arabic Microcrystalline Cellulose Modified Cellulose Stearic Acid Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: Take 1 capsule daily, without food. Best when taken as directed by a qualified healthcare professional.

Warnings & Precautions

Warnings: Keep out of reach of children.

Consult with a licensed physician, pharmacist, naturopath or other qualified healthcare professional prior to taking dietary supplements. Sealed for your protection. Do not use if seal is missing or broken.

This product is not manufactured with milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soy, sesame, or gluten. Produced in an FDA registered, third-party audited, and cGMP-compliant facility that may process other products that contain these allergens or ingredients.

Formulation Notes

Nicotinamide Mononucleotide

Formulated without Gluten GMOs Soy

This product is not manufactured with milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soy, sesame, or gluten.

Additional Information

Store in a cool, dry place. Protect from heat, light, and moisture.

Metadata

Product Details

UPC / SKU8 98220 01920 5
DSLD Entry Date2023-11-22
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandCalifornia Gold Nutrition
DSLD ID299661
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
54
Avg Quality
4
Rct
2
Meta Analysis
2
Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025 PubMed DOI
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024 PubMed DOI
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.) PubMed DOI
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience PubMed DOI
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024 PubMed DOI
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023 PubMed DOI
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →
Compare

Similar Products

NMN Nicotinamide Mononucleotide 250 mg
Double Wood Supplements · Capsule
100
Nicotinamide Mononucleotide 125 mg
SuperSmart · Capsule
100
NMN Nicotinamide Mononucleotide 250 mg
ForestLeaf · Capsule
100
LIPO NMN
Alive By Science · Capsule
100
NMN Nicotinamide Mononucleotide
GeneX Formulas · Capsule
100
View all Nmn products →
Nmn research Best Nmn All Nmn products More from California Gold Nutrition View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.